OKUR

ONKURE THERAPEUTICS INC

OKUR·68277Q105·US·Common Stock·Healthcare - Biotechnology-Activist

OKUR (ONKURE THERAPEUTICS INC) is held by 29 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($16.6M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($5M), VANGUARD CAPITAL MANAGEMENT LLC ($2.4M). Net institutional sentiment: Mixed.

29
Holders
Avg rating(6 Elite)
$29.2M
Total Value
58% (34)
Fund Consensus
18 buying - 13 selling
OKURSmart Money Verdict
View all
Held by 29 funds
6 elite
Who's Trading
InsiderLALeverone Jason A.Sell $1KJun 22, 2026
ActivistBLBVF PARTNERS L P/IL5.3%May 27, 2026
ActivistADADAR1 Capital Management, LLC6.0%May 15, 2026
ActivistTETrails Edge Capital Partners, LP6.0%Apr 7, 2026
ActivistSTStepStone Group LP6.6%Apr 7, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.9.9%Apr 7, 2026
ActivistABAI Biotechnology LLC20.0%Apr 7, 2026
InsiderLALeverone Jason A.Sell $1KMar 23, 2026
InsiderSASaccomano Nicholas ASell $357.46Mar 23, 2026
InsiderLALeverone Jason A.Sell $896.25Dec 22, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
4M$16.6M0.2%+45.08%
47
New
1.2M$5M0.0%+45.08%
37
New
582,477$2.4M0.0%+45.08%
36
Increased
377,250(+52.5%)$1.6M0.0%+27.22%
36
Unchanged
269,895$1.1M0.0%-48.25%
0
Decreased
99,900(-77.5%)$413,5860.0%+42.42%
0
Increased
98,750(+27.5%)$408,8450.0%-36.94%
20
Decreased
49,587(-5.9%)$205,2900.0%+28.73%
0
New
44,551$184,4410.0%+45.08%
31
New
43,371$179,5560.0%+45.08%
35
Decreased
37,587(-83.2%)$155,6100.0%-47.52%
0
New
36,444$150,8780.0%+45.08%
31
Increased
34,129(+91.7%)$141,2940.0%+47.70%
35
New
30,499$126,2660.0%+45.08%
31
Increased
26,812(+38.1%)$111,0020.0%+48.74%
20
Decreased
25,000(-8.2%)$103,5000.0%+43.93%
0
Increased
24,262(+114.3%)$100,4450.0%+17.12%
35
Unchanged
19,903$82,3980.0%-42.17%
0
Decreased
14,327(-42.6%)$59,3140.0%+50.57%
0
Increased
13,500(+22.7%)$55,8900.0%+18.92%
17

Showing 1-20 of 34

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used